Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: North American Vaccine (NVX)

No earlier versions found for this Subject.

Return to North American Vaccine (NVX)

NEWS-North American Vaccine and Chiron Behring Form Marketing Alliance for Germany.

NVX and Chiron Behring announced today that they had signed a definitive agreement for Chiron Behring to market North American Vaccine's DTaP vaccine and DTaP-Polio vaccine in Germany and Austria.
The agreement provides for an up-front payment and milestone payments and revenue from the sale of the vaccine products to Chiron Behring.

"We are looking forward to marketing the two products and to establishing a growing relationship between the two companies" said Beino von Prondzynski, CEO of Chiron Behring.
The full text of the release will be on NVX's homepage. :-} :-}